Jonathan Weiss /
15 June 2016Big Pharma

German Supreme Court grants Eli Lilly appeal in Alimta patent case

The German Federal Supreme Court has granted Eli Lilly an appeal in the patent infringement case against its rival Actavis regarding the Alimta drug.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at